Technology News and Research

RSS

NTNU’s EIR software to be showcased at 7th World Research Congress of the EAPC

What happens when doctors cannot cure a disease? What is the best way to make patients comfortable and have the best quality of life possible in the time they have left? Researchers at the Norwegian University of Science and Technology (NTNU) have developed software that can be used with an iPad or other tablet to help record patient pain levels to help doctors in developing further treatment.

6 Jun 2012

Transgenomic introduces ICE COLD-PCR mutation detection technology

Transgenomic, Inc. today announced the commercial launch of its ICE COLD-PCR mutation detection technology, a breakthrough technology enabling unmatched sensitivity and complete DNA mutation detection using the standard sequencing equipment already installed in laboratories around the world.

6 Jun 2012

SANUWAVE’s ESWT stimulates proliferation of cambium cells for bone generation

SANUWAVE Health, Inc., today announced the publication of peer-reviewed, preclinical research that demonstrates the ability of the Company's Extracorporeal Shock Wave Technology (ESWT) to stimulate proliferation of periosteal adult stem cells (cambium cells) within the body and subsequently form bone.

6 Jun 2012

inVentiv Health acquires Kazaam Interactive

inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has acquired Kazaam Interactive, a full-service interactive agency providing comprehensive solutions and services for healthcare agencies and brands.

6 Jun 2012

Altapure, ITT Exelis to launch new model of disinfection system

ITT Exelis and Altapure, LLC are launching a new model of their state-of-the-art disinfection system at the Association for Professionals in Infection Control and Epidemiology annual conference this week in San Antonio, Texas.

6 Jun 2012

BioMed Protect’s Sanotracin RTU rapidly and effectively kills C. difficile within 3 minutes

In the United States Clostridium difficile or "C. difficile" is now recognized as one of the most dangerous and fastest growing Healthcare Acquired Infections (HAIs) in existence. Now surpassing even Staphylococcus aureus (MRSA), C. difficile infections tripled between 2000 and 2005.

6 Jun 2012

GE Healthcare acquires XPRO

Today, GE Healthcare announced the acquisition of XPRO, a Brazilian Interventional X-ray equipment manufacturer company with over 15 years of experience and with more than 120 systems installed at private customer sites.

6 Jun 2012

Apache, ANSYS’ RedHawk and Totem products achieve TSMC Phase I 20 nm certification

ANSYS and subsidiary Apache Design announced today that their RedHawk and Totem products achieved TSMC Phase I 20 nm certification. TSMC certified the tools for 20 nm design rule manuals (DRMs) and SPICE models.

5 Jun 2012

Scientists develop new low-dose CT-scan technique

Scientists have developed an X-ray imaging method that could drastically improve the contrast of computed tomography (CT) scans whilst reducing the radiation dose deposited during the scan. The new method is based on the combination of the high contrast obtained by an X-ray technique known as grating interferometry with the three-dimensional capabilities of CT.

5 Jun 2012

Statisticians devise new predictive algorithm for future medical conditions

Analyzing medical records from thousands of patients, statisticians have devised a statistical model for predicting what other medical problems a patient might encounter.

5 Jun 2012

Republicans schedule repeal votes to bring attention to health law

One of the highest profile efforts involves the repeal of the health law's medical device tax, and one proposal also includes language that would trim the measure's insurance subsidies for low- and middle-income taxpayers.

From Medtronic 5 Jun 2012

Parkinson’s vaccine: worldwide first clinical trial begins

The worldwide first clinical trial for the development of a Parkinson´s vaccine has now been started by AFFiRiS AG.

5 Jun 2012

New data from CardioFocus’ HeartLight EAS clinical study on AF

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new worldwide data with its technology was presented during the scientific sessions at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA last month.

5 Jun 2012

Scientists discover neural mechanism for conscious perception

When people close their eyes, they can form mental images of things that exist only in their minds. Neuroscientists studying this phenomenon at medical schools in the Texas Medical Center believe that there may be a way to use these mental images to help some of the estimated 39 million people worldwide who are blind.

5 Jun 2012

Researchers identify predictive biomarker for Parkinson's disease

Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.

5 Jun 2012

Force 3 acquires secureRAD

Force 3, delivering innovative technology solutions, today announced the acquisition of secureRAD, a provider of disruptive technology solutions for the medical imaging industry.

5 Jun 2012

Chatham, Baxter partner to develop and commercialize hemophilia B gene therapy treatment

Baxter International Inc. today announced that it has entered into an exclusive global agreement with Chatham Therapeutics, LLC, an affiliate of Asklepios BioPharmaceutical, Inc. (AskBio), for the development and commercialization of potential treatments for hemophilia B utilizing Chatham's gene therapy technology.

From Baxter International Inc. 5 Jun 2012

FDA approves Arteriocyte’s ACD-A for use with Magellan system

Arteriocyte Medical Systems, Inc. announced today approval by the U.S. Food and Drug Administration (FDA) to manufacture and distribute the Arteriocyte Medical Systems brand of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation System.

5 Jun 2012

New data from ImmunoGen’s SAR3419 Phase I study on CD19+ NHL

ImmunoGen, Inc., a biotechnology company, today announced the presentation of new clinical data for the investigational compound, SAR3419, at the American Society of Clinical Oncology (ASCO) annual meeting taking place in Chicago, IL.

4 Jun 2012

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.

4 Jun 2012